147 related articles for article (PubMed ID: 4149551)
1. [A controlled clinical trial of a new bladder spasmolytic drug--Urispadol].
Frimodt-Moller C; Hald T; Folkenborg O
Ugeskr Laeger; 1973 Oct; 135(43):2321-4. PubMed ID: 4149551
[No Abstract] [Full Text] [Related]
2. [Editorial: Hyperactivity of the bladder].
Hald T
Ugeskr Laeger; 1973 Oct; 135(43):2333-4. PubMed ID: 4149552
[No Abstract] [Full Text] [Related]
3. [Neurogenic disturbances of the bladder treated with flavoxate (Urispadol)].
Pedersen E; Bjarnason EV; Hansen PH
Ugeskr Laeger; 1973 Oct; 135(43):2313-7. PubMed ID: 4590632
[No Abstract] [Full Text] [Related]
4. Emepronium bromide in the management of nightly urinary frequency and urinary incontinence.
Kagan G
Practitioner; 1970 May; 204(223):705-10. PubMed ID: 5431337
[No Abstract] [Full Text] [Related]
5. Clean, intermittent self-catheterization in the treatment of urinary tract disease.
Lapides J; Diokno AC; Silber SJ; Lowe BS
Trans Am Assoc Genitourin Surg; 1971; 63():92-6. PubMed ID: 5137796
[No Abstract] [Full Text] [Related]
6. A symptomatic and cystometric comparison of terodiline with emepronium in the treatment of women with frequency, urgency and incontinence.
Sole GM; Arkell DG
Scand J Urol Nephrol Suppl; 1984; 87():55-7. PubMed ID: 6399955
[TBL] [Abstract][Full Text] [Related]
7. [Neurogenic dysfunction of the bladder in disseminated sclerosis. A retrospective material].
Hebjorn S
Ugeskr Laeger; 1973 Oct; 135(43):2317-21. PubMed ID: 4775654
[No Abstract] [Full Text] [Related]
8. A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence.
Stanton SL
J Urol; 1973 Nov; 110(5):529-32. PubMed ID: 4750896
[No Abstract] [Full Text] [Related]
9. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
[TBL] [Abstract][Full Text] [Related]
10. [Uroflowmetry in the diagnosis of neurogenic bladder disorders].
Schneider E
Nervenarzt; 1975 Apr; 46(4):203-7. PubMed ID: 52127
[No Abstract] [Full Text] [Related]
11. A trial of emepronium bromide for the treatment of urinary incontinence in the elderly mentally ill.
Williams AJ; Prematalake JK; Palmer RL
Pharmatherapeutica; 1981; 2(8):539-42. PubMed ID: 7019932
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of irritable bladder and urinary incontinence].
Thüroff JW; Frohneberg D; Petri E; Jonas U
Dtsch Med Wochenschr; 1981 Feb; 106(7):215-7. PubMed ID: 6162632
[No Abstract] [Full Text] [Related]
13. Emepronium bromide in urinary incontinence.
Brocklehurst JC; Armitage P; Jouhar AJ
Age Ageing; 1972 Aug; 1(3):152-7. PubMed ID: 4593683
[No Abstract] [Full Text] [Related]
14. [Drug therapy of female urinary incontinence].
Hannappel J; Lutzeyer W
Dtsch Med Wochenschr; 1981 Aug; 106(35):1102-4. PubMed ID: 6114846
[No Abstract] [Full Text] [Related]
15. [Urination disorders in various age groups].
Marquardt H
Z Allgemeinmed; 1972 Oct; 48(30):1405-10. PubMed ID: 4119563
[No Abstract] [Full Text] [Related]
16. [Clinical effect of propiverine hydrochloride on urinary incontinence].
Watanabe H; Uchida M; Kojima M
Hinyokika Kiyo; 1998 Mar; 44(3):199-206. PubMed ID: 9589886
[TBL] [Abstract][Full Text] [Related]
17. Treatment of detrusor hyperreflexia in multiple sclerosis: a double-blind, crossover clinical trial comparing methantheline bromide (Banthine), flavoxate chloride (Urispas) and meladrazine tartrate (Lisidonil).
Hebjorn S
Urol Int; 1977; 32(2-3):209-17. PubMed ID: 20683
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacotherapy of functional disorders of the lower urinary tract in the female. 2: Drug therapy of stress incontinence, bladder muscle weakness and increased bladder outflow resistance].
Schumacher T; Peters FD
Fortschr Med; 1984 Sep; 102(36):906-8. PubMed ID: 6489903
[No Abstract] [Full Text] [Related]
19. [Treatment of motor dysfunction of the urinary bladder].
Gaudenz R; Buess H
Fortschr Med; 1978 Sep; 96(35):1777-82. PubMed ID: 738692
[TBL] [Abstract][Full Text] [Related]
20. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
